文献速递眼底病与葡萄膜炎

年龄相关性和糖尿病视网膜病变患者玻璃体的蛋白质组景观

The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

该研究采用液相色谱-质谱联用分析34例玻璃体样本(干性AMD 6例、新生血管性AMD 10例、增殖性糖尿病视网膜病变9例、视网膜前膜9例)的蛋白质组,以视网膜前膜为参照进行无标记相对定量。共鉴定677种蛋白质,各患者组显示特征性通路富集:干性AMD为氧化应激、nAMD为黏着斑、PDR为补体和凝血级联。胆碱酯酶在干性AMD中特异性上调,核糖核酸酶(胰腺;RNAS1)和丝氨酸羧肽酶( probable;CPVL)在两种AMD形式中均上调。

要点

  • 干性AMD玻璃体特征性富集氧化应激通路,nAMD富集黏着斑通路,PDR富集补体和凝血级联通路。
  • 胆碱酯酶在干性AMD中特异性上调,核糖核酸酶(胰腺;RNAS1)和丝氨酸羧肽酶(probable;CPVL)在两种AMD形式中均上调。
  • 共鉴定677种蛋白质,为干性AMD生物标志物定义提供初步依据。

核心结论

  • 不同患者组的特异性通路及特征性差异调控蛋白的鉴定为干性AMD生物标志物的定义提供了第一步。

研究设计与样本

  • 研究分析了34例玻璃体样本的蛋白质组:干性AMD 6例、nAMD 10例、PDR 9例、ERM 9例,采用液相色谱-质谱联用,以ERM为参照组进行无标记相对定量,并通过生物信息学流程进行聚类和基因集富集分析,部分差异调控蛋白用ELISA验证。

主要发现

  • 共鉴定677种蛋白质并在四组患者玻璃体中相对于ERM进行相对定量。
  • 干性AMD特征性富集「氧化应激」通路,nAMD富集「黏着斑」通路,PDR富集「补体和凝血级联」通路。
  • 胆碱酯酶在干性AMD中特异性上调。
  • 核糖核酸酶(胰腺;RNAS1)与丝氨酸羧肽酶(probable;CPVL)在两种AMD形式中均上调。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: In contrast to neovascular AMD (nAMD), no treatment option exists for dry AMD. Hence, the identification of specific biomarkers is required to facilitate diagnosis and therapy of dry AMD. METHODS: The proteome of 34 vitreous humor samples (dry AMD: n = 6; nAMD: n = 10; proliferative diabetic retinopathy [PDR]: n = 9; epiretinal membrane [ERM]: n = 9) was analyzed by liquid chromatography coupled mass spectrometry. Then, label-free relative quantification of dry AMD, nAMD, and PDR relative to ERM, which was defined as the reference group, was performed. Application of a bioinformatics pipeline further analyzed the vitreous proteome by cluster and gene set enrichment analysis. A selection of differentially regulated proteins was validated by ELISA. RESULTS: A total of 677 proteins were identified in the vitreous of the four patient groups and quantified relatively to ERM. Different clusters of regulated proteins for each patient group were identified and showed characteristic enrichment of specific pathways including "oxidative stress" for dry AMD, "focal adhesion" for nAMD, and "complement and coagulation cascade" for PDR patients. We identified cholinesterase (CHLE) to be specifically upregulated in dry AMD and ribonuclease (pancreatic; RNAS1) together with serine carboxypeptidase (probable; CPVL) to be upregulated in both forms of AMD. CONCLUSIONS: The described pathways specific for the different patient groups and the identification of characteristic differentially regulated proteins provide a first step toward the definition of biomarkers for dry AMD. The presented data will facilitate the investigation of mechanistic connections of proteins to the respective disease.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Schori C, Trachsel C, Grossmann J, et al. The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease. Invest Ophthalmol Vis Sci. 2018. PMID: 30025106. doi:10.1167/iovs.18-24122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。